All In Biotech

Drug Trial Radar · NCT04535986

A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD

A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks (With a 48-week Safety Subset) in Subjects With Moderate to Severe COPD

Last checked: Nov 20, 2026Latest source record: Nov 13, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 763 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

763

Actual

Start

Sep 29, 2020

Primary completion

Sep 12, 2022

Study completion Dec 2, 2022

Sponsor

Sponsor type
Industry
Collaborators
IQVIA Pty Ltd
First posted
Sep 2, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of ensifentrine in patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).

Conditions

  • Chronic Obstructive Pulmonary Disease

Interventions

  • EnsifentrineDrug

    Dosage Formulation: Ensifentrine Nebulizer suspension Dosage 3mg Frequency: Twice Daily for 24 weeks or 48 weeks

  • PlaceboDrug

    Dosage Formulation: Ensifentrine Placebo Nebulizer solution Frequency: Twice Daily for 24 weeks or 48 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Least Square (LS) Mean Change From Baseline in Average Forced Expiratory Volume in 1 Second (FEV1) Area Under the Curve Over 12 Hours (AUC0-12h) at Week 12Time frame: Baseline (pre-dose on Day 1) and Week 12

Locations

122 sites in 12 countries. Site status is shown where the registry gives one.

  • Phoenix Medical Group

    Peoria, Arizona

  • AMR Tempe

    Tempe, Arizona

  • Beach Physicians Medical Group

    Huntington Beach, California

  • Downtown LA Research Center, Inc.

    Los Angeles, California

  • Clinical Research of West Florida, Inc.

    Clearwater, Florida

  • St. Francis Medical Institute

    Clearwater, Florida

  • Qway Research, LLC

    Hialeah, Florida

  • Multi-Specialty Research Associates, Inc.

    Lake City, Florida

  • Elite Clinical Research

    Miami, Florida

  • Global Research Solutions Corp

    Miami, Florida

  • Phoenix Medical Research

    Miami, Florida

  • Florida Institute for Clinical Research

    Orlando, Florida

  • Precision Clinical Research

    Sunrise, Florida

  • Clinical Research of West Florida, Inc.

    Tampa, Florida

  • iResearch Atlanta, LLC

    Decatur, Georgia

  • IACT Health

    Rincon, Georgia

  • In-Quest Medical Research, LLC

    Suwanee, Georgia

  • John Hopkins University School of Medicine

    Baltimore, Maryland

  • Pulmonary Research Institute of SE Michigan

    Farmington Hills, Michigan

  • Midwest Chest Consultants

    Saint Charles, Missouri

  • The Clinical Research Center, LLC

    St Louis, Missouri

  • Sierra Clinical Research

    Las Vegas, Nevada

  • Alliance for Multispecialty Research, LLC

    Las Vegas, Nevada

  • IMA Clinical Research, LLC

    New York, New York

  • Monroe Biomedical Research

    Monroe, North Carolina

  • Remington Davis Clinical Research

    Columbus, Ohio

  • Velocity Clinical Research - Grants Pass

    Grants Pass, Oregon

  • Clinical Research Associates of Central PA, LLC

    DuBois, Pennsylvania

  • University of Pittsburgh Physicians, Emphysema/COPD Research Center

    Pittsburgh, Pennsylvania

  • Medtrial

    Columbia, South Carolina

  • MDFirst Research

    Lancaster, South Carolina

  • Chattanooga Research & Medicine (CHARM)

    Chattanooga, Tennessee

  • MultiSpecialty Clinical Research, Inc.

    Johnson City, Tennessee

  • New Phase Research Development

    Knoxville, Tennessee

  • West Houston Clinical Research Services

    Houston, Texas

  • LinQ Research, LLC

    Pearland, Texas

  • Sherman Clinical Research

    Sherman, Texas

  • Pulmonary Research of Abingdon, LLC

    Abingdon, Virginia

  • TPMG Clinical Research Williamsburg

    Williamsburg, Virginia

  • SHATPPD - Haskovo, EOOD

    Haskovo, Bulgaria

Showing 40 of 122 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.